Sports Medicine

, Volume 34, Issue 12, pp 779–807 | Cite as

Are Cardiovascular Disease and Osteoporosis Directly Linked?

  • Crystal Whitney
  • Darren E. R. Warburton
  • Jiri Frohlich
  • Sammy Y. Chan
  • Heather McKay
  • Karim Khan
Leading Article

Abstract

For years, osteoporosis and cardiovascular disease were thought to be two independent consequences of aging; however, mounting evidence supports an association between these diseases. Recently, a widespread class of cholesterol-lowering drugs known as statins have demonstrated (in rodents and cell cultures) the ability to induce bone formation. This finding is significant since current therapies are limited to the prevention or slowing down of bone loss rather than (enhancing/improving) bone formation. In humans, the ability of statins to generate new bone has not been consistent; however, several investigations have demonstrated a dramatic decrease in fracture risk. Although it has been proposed that statins induce new bone via increased bone morphogenetic protein-2, other conditions affected by statins such as dyslipidaemia, vascular calcification, endothelial dysfunction and impaired nitric oxide expression, may also contribute to the cardiovascular and bone health paradigm. Furthermore, the role of physical activity and its influence on cardiovascular and bone health, especially in postmenopausal women, may contribute to the discrepancy of findings in human data. In summary, it remains to be determined if statins contribute to bone health via improvements in vascular health or by pleiotropic properties unique to their pharmacology. This review provides information on our current understanding of the bone and cardiovascular association, as well as on novel areas of research to further our current understanding of these conditions.

References

  1. 1.
    Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340(8828): 1111–5PubMedGoogle Scholar
  2. 2.
    O’Driscoll G, Green D, Taylor RR. Simvastatin an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997; 95(5): 1126–31PubMedGoogle Scholar
  3. 3.
    Wilson SH, Simari R, Best P, et al. Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering. Arteriocler Thromb Vasc Biol 2001; 21: 122–8Google Scholar
  4. 4.
    Anderson T, Elstein E, Haber H, et al. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol 2000; 35(1): 67–70Google Scholar
  5. 5.
    Mancini G, Henry G, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND (Trial on Reversing ENdothelial Dysfuncton) study. Circulation 1996; 94(3): 258–65PubMedGoogle Scholar
  6. 6.
    Hornig B, Arakawa N, Haussmann D, et al. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998; 98(25): 2842–8PubMedGoogle Scholar
  7. 7.
    Celermajer D, Sorenson K, Spiegelhalter D, et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994; 24(2): 471–6PubMedGoogle Scholar
  8. 8.
    Clarkson P, Montgomery H, Mullen M, et al. Exercise training enhances endothelial function in young men. J Am Coll Cardiol 1999; 33(5): 1379–85PubMedGoogle Scholar
  9. 9.
    Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol 2001; 21(11): 1712–9PubMedGoogle Scholar
  10. 10.
    Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344(19): 1383–9Google Scholar
  11. 11.
    Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333(20): 1301–7PubMedGoogle Scholar
  12. 12.
    Sacks FM, Pfefferr MA, Move LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335(14): 1001–9PubMedGoogle Scholar
  13. 13.
    LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339(19): 1349–57Google Scholar
  14. 14.
    Downs J, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 1998; 279(20): 1615–22PubMedGoogle Scholar
  15. 15.
    Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285(19): 2486–97Google Scholar
  16. 16.
    Kannel WB, Castelli WP, Gordon T, et al. Serum cholesterol, lipoproteins and the risk of coronary heart disease: the Framingham Study. Ann Intern Med 1971; 74(1): 1–12PubMedGoogle Scholar
  17. 17.
    Pitt B, Waters D, Brown WV, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 1999; 341(2): 70–6PubMedGoogle Scholar
  18. 18.
    Packard CJ. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 1998; 97(15): 1440–5Google Scholar
  19. 19.
    Massy ZA, Keane WF, Kasiske BL. Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction? Lancet 1996; 347(8994): 102–3PubMedGoogle Scholar
  20. 20.
    Panza J, Cannon III R. Endothelium, nitric oxide, and atherosclerosis: from basic mechanisms to clinical implications. 1st ed. Armonk (NY): Futura Publishing Company Inc., 1999Google Scholar
  21. 21.
    Vita J, Treasure C, Nabel E, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81(2): 491–7PubMedGoogle Scholar
  22. 22.
    Zeiher A, Drexler H, Saurbier B, et al. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Investig 1993; 92(2): 652–62PubMedGoogle Scholar
  23. 23.
    Cooke JP, Tsao P. Is NO an endogenous antiatherogenic molecule? Arteriocler Thromb 1994; 14(5): 653–5Google Scholar
  24. 24.
    Gibbons G, Dzau V. The emerging concept of vascular remodeling. N Engl J Med 1994; 330(20): 1431–8PubMedGoogle Scholar
  25. 25.
    Adams M, Jessup W, Hailstones D, et al. L-Arginine reduces monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules. Circulation 1997; 95(3): 662–8PubMedGoogle Scholar
  26. 26.
    Wang PS, Solomon DH, Mogun H, et al. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 2000; 283(24): 3211–6PubMedGoogle Scholar
  27. 27.
    Sugiyama M, Kodama T, Konishi K, et al. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells. Biochem Biophys Res Commun 2000; 271(3): 688–92PubMedGoogle Scholar
  28. 28.
    Oxlund H, Dalstra M, Andreassen TT. Statin given perorally to adult rats increases cancellous bone mass and compressive strength. Calcif Tissue Int 2001; 69(5): 299–304PubMedGoogle Scholar
  29. 29.
    Ohnaka K, Shimoda S, Nawata J, et al. Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts. Biochem Biophys Res Commun 2001; 287(2): 337–42PubMedGoogle Scholar
  30. 30.
    Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999; 286(5446): 1946–55PubMedGoogle Scholar
  31. 31.
    Meier CR, Schlienger RG, Kraenzlin ME, et al. HMG-CoA reductase inhibitors and the risk of fractures. JAMA 2000; 283(24): 3205–10PubMedGoogle Scholar
  32. 32.
    Maritz FJ, Conradie MM, Hulley PA, et al. Effect of statins on bone mineral density and bone histomorphometry in rodents. Arterioscler Thromb Vasc Biol 2001; 21(10): 1636–41PubMedGoogle Scholar
  33. 33.
    Maeda T, Matsunuma A, Kawane T, et al. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun 2001; 280(3): 874–7PubMedGoogle Scholar
  34. 34.
    Edwards C, Hart D, Spector T. Oral statins and increased bone-mineral density in postmenopausal women. Lancet 2000; 355(9222): 2218–9PubMedGoogle Scholar
  35. 35.
    Chung Y-S, Lee M-D, Lee S-K, et al. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. J Clin Endocrinol Metab 2000; 85(3): 1137–42PubMedGoogle Scholar
  36. 36.
    Chan KA, Andrade SE, Boles M, et al. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet 2000; 355(9222): 2185–8PubMedGoogle Scholar
  37. 37.
    Bjarnason N, Riis B, Christiansen C. The effect of fluvastatin on parameters of bone remodeling. Osteoporos Int 2001; 12(5): 380–4PubMedGoogle Scholar
  38. 38.
    Watanabe S, Fukumoto S, Takeuchi Y, et al. Effects of 1-year treatment with fluvastatin or pravastatin on bone. Am J Med 2001; 110(7): 584–7PubMedGoogle Scholar
  39. 39.
    Woo J-T, Kasai S, Stern P, et al. Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts. J Bone Miner Res 2000; 15(4): 650–62PubMedGoogle Scholar
  40. 40.
    Chan M, Mak T, Chiu R, et al. Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolaemia. J Clin Endocrinol Metab 2001; 86(9): 4556–9PubMedGoogle Scholar
  41. 41.
    Reid IR, Hague W, Emberson J, et al. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analyses of a randomised controlled trial. Lancet 2001; 337(9255): 509–12Google Scholar
  42. 42.
    Pasco J, Kotowicz M, Henry M, et al. Statin use, bone mineral density, and fracture risk. Arch Intern Med 2002; 162(5): 537–40PubMedGoogle Scholar
  43. 43.
    Sirola J, Honkanen R, Kroger H, et al. Relation of statin use and bone loss: a prospective population-based cohort study in early postmenopausal women. Osteoporos Int 2002; 13(7): 537–41PubMedGoogle Scholar
  44. 44.
    Stein E, Farnier M, Waldstreicher J, et al. Effects of statins on biomarkers of bone metabolism: a randomised trial. Nutr Metab Cardiovasc Dis 2001; 11(2): 84–7PubMedGoogle Scholar
  45. 45.
    Looker A, Bauer D, Chesnut III C, et al. Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporos Int 2000; 11(6): 467–80PubMedGoogle Scholar
  46. 46.
    van Staa T-P, Wegman S, de Vries F, et al. Use of statins and risk of fractures. JAMA 2001; 285(14): 1850–5PubMedGoogle Scholar
  47. 47.
    Safeer R, Lacivita C. Choosing drug therapy for patients with hyperlipidemia. Am Fam Physician 2000; 61(11): 3371–82PubMedGoogle Scholar
  48. 48.
    Marcus R, Feldman D, Kelsey J. Osteoporosis. San Diego (CA): Academic Press, 1996Google Scholar
  49. 49.
    Callister TQ, Raggi P, Cooil B, et al. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 1998; 339(27): 1972–8PubMedGoogle Scholar
  50. 50.
    Parhami F, Morrow A, Balucan J, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation: a possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 1997; 17(4): 680–7PubMedGoogle Scholar
  51. 51.
    Parhami F, Jackson S, Tintut Y, et al. Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 1999; 14(12): 2067–78PubMedGoogle Scholar
  52. 52.
    Parhami F, Tintut Y, Beamer W, et al. Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res 2001; 16(1): 182–8PubMedGoogle Scholar
  53. 53.
    Aoyagi K, Ross P, Orloff J, et al. Low bone density is not associated with aortic calcification. Calcif Tissue Int 2001; 69(1): 20–4PubMedGoogle Scholar
  54. 54.
    Vogt M, Valentin R, Forrest K, et al. Bone mineral density and aortic calcification: the Study of Osteoporotic Fractures. J Am Geriatr Soc 1997; 45(2): 140–5PubMedGoogle Scholar
  55. 55.
    Yamaguchi T, Sugimoto T, Yano S, et al. Plasma lipids and osteoporosis in postmenopausal women. Endocr J 2002; 49(2): 211–7PubMedGoogle Scholar
  56. 56.
    Uyama O, Yoshimoto Y, Yamamoto Y, et al. Bone changes and carotid atherosclerosis in postmenopausal women. Stroke 1997; 28(9): 1730–2PubMedGoogle Scholar
  57. 57.
    Barengolts E, Berman M, Kukreja S, et al. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 1998; 62(3): 209–13PubMedGoogle Scholar
  58. 58.
    Browner W, Seeley D. Non-trauma mortality in elderly women with low bone mineral density. Lancet 1991; 338(8763): 355–8PubMedGoogle Scholar
  59. 59.
    Vogt M, Cauley J, Kuller L, et al. Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. J Bone Miner Res 1997; 12(2): 283–9PubMedGoogle Scholar
  60. 60.
    von der Recke P, Hansen M, Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 1999; 106(3): 273–8PubMedGoogle Scholar
  61. 61.
    Hak A, Pols H, van Hemert A, et al. Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol 2000; 20(8): 1926–31PubMedGoogle Scholar
  62. 62.
    Kado D, Browner W, Blackwell T, et al. Rate of bone loss is associated with mortality in older women: a prospective study. J Bone Miner Res 2000; 15(10): 1974–80PubMedGoogle Scholar
  63. 63.
    Kiel D, Kauppila L, Cupples L, et al. Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif Tissue Int 2001; 68(5): 271–6PubMedGoogle Scholar
  64. 64.
    Helfrich M, Evans D, Grabowski P, et al. Expression of nitric oxide synthase isoforms in bone and bone cell cultures. J Bone Miner Res 1997; 12(7): 1108–15PubMedGoogle Scholar
  65. 65.
    Fox S, Chow J. Nitric oxide and synthase expression in bone cells. Bone 1998; 23(1): 1–6PubMedGoogle Scholar
  66. 66.
    Klein-Nulend J, Helfrich M, Sterck J, et al. Nitric oxide response to shear stress by human bone cell cultures is endothelial nitric oxide synthase dependent. Biochem Biophys Res Commun 1998; 250(1): 108–14PubMedGoogle Scholar
  67. 67.
    Mancini L, Moradi-Bidhendi N, Becherini L, et al. The biphasic effects of nitric oxide in primary rat osteoblasts are cGMP dependent. Biochem Biophys Res Commun 2000; 274(2): 477–81PubMedGoogle Scholar
  68. 68.
    MacIntyre I, Zaidi M, Alam A, et al. Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci U S A 1991; 88(7): 2936–40PubMedGoogle Scholar
  69. 69.
    Holliday L, Dean A, Lin R, et al. Low NO concentrations inhibito osteoclast formation in mouse marrow cultures by cGMP-dependent mechanism. Am J Physiol 1997; 272 (3 Pt 2): F283–91PubMedGoogle Scholar
  70. 70.
    Wimalawansa S, De Marco G, Gangula P, et al. Nitric oxide donor alleviates ovariectomy-induced bone loss. Bone 1996; 18(4): 301–4PubMedGoogle Scholar
  71. 71.
    Turner C, Owan I, Jacob D, et al. Effects of nitric oxide synthase inhibitors on bone formation in rats. Bone 1997; 26(6): 487–90Google Scholar
  72. 72.
    Jamal S, Browner W, Bauer D, et al. Intermittent use of nitrates increases bone mineral density: the study of osteoporotic fractures. J Bone Miner Res 1998; 13(11): 1755–9PubMedGoogle Scholar
  73. 73.
    Armour K, Van’t Hof R, Grabowski P, et al. Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis. J Bone Miner Res 1999; 14(12): 2137–42PubMedGoogle Scholar
  74. 74.
    MacPherson H, Noble B, Ralston S. Expression and functional role of nitric oxide synthase isoforms in human osteoblast-like cells. Bone 1999; 24(3): 179–85PubMedGoogle Scholar
  75. 75.
    Zaman G, Pitsillides A, Rawlinson S, et al. Mechanical strain stimulates nitric oxide production by rapid activation of endothelial nitric oxide synthase in osteocytes. J Bone Miner Res 1999; 14(7): 1123–31PubMedGoogle Scholar
  76. 76.
    McAllister T, Du T, Frangos J. Fluid shear stress stimulates prostaglandin and nitric oxide release in bone marrow-derived preosteoclast-like cells. Biochem Biophys Res Commun 2000; 270(2): 643–8PubMedGoogle Scholar
  77. 77.
    O’Shaughnessy M, Polak J, Afzal F, et al. Nitric oxide mediates 17β-estradiol-stimulated human and rodent osteoblast proliferation and differentiation. Biochem Biophys Res Commun 2000; 277(3): 604–10PubMedGoogle Scholar
  78. 78.
    Wimalawansa S. Restoration of ovariectomy-induced osteopenia by nitroglycerin. Calcif Tissue Int 2000; 66(1): 56–60PubMedGoogle Scholar
  79. 79.
    Aguirre J, Buttery L, O’Shaughnessy M, et al. Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity. Am J Pathol 2001; 158(1): 247–57PubMedGoogle Scholar
  80. 80.
    Armour K, Armour K, Gallagher M, et al. Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology 2001; 142(2): 760–6PubMedGoogle Scholar
  81. 81.
    Samuels A, Perry M, Gibson R, et al. Role of endothelial nitric oxide synthase in estrogen-induced osteogenesis. Bone 2001; 29(1): 24–9PubMedGoogle Scholar
  82. 82.
    Watanuki M, Sakai A, Sakata T, et al. Role of inducible nitric oxide synthase in skeletal adaptation to acute increases in mechanical loading. J Bone Miner Res 2002; 17(6): 1015–25PubMedGoogle Scholar
  83. 83.
    Riancho J, Salas E, Zarrabeitia M, et al. Expression and functional role of nitric oxide synthase in osteoblast-like cells. J Bone Miner Res 1995; 10(3): 439–46PubMedGoogle Scholar
  84. 84.
    Turner C, Takano Y, Owan I, et al. Nitric oxide inhibitor LNAME suppresses mechanically induced bone formation in rats. Am J Physiol 1996; 270 (4 Pt 1): E634–9PubMedGoogle Scholar
  85. 85.
    Fox S, Chambers T, Chow J. Nitric oxide is an early mediator of the increase in bone formation by mechanical stimulation. Am J Physiol 1996; 270 (6 Pt 1): E955–60PubMedGoogle Scholar
  86. 86.
    Kasten T, Collin-Osdoby P, Patel N, et al. Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase. Proc Natl Acad Sci U S A 1994; 91(9): 3569–73PubMedGoogle Scholar
  87. 87.
    Rich G, Mudge G, Laffel G, et al. Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients. J Heart Lung Transplant 1992; 11(5): 950–8PubMedGoogle Scholar
  88. 88.
    Berguer D, Krieg M-A, Thiebaud D, et al. Osteoporosis in heart transplant recipients: a longitudinal study. Transplant Proc 1994; 26(5): 2649–51PubMedGoogle Scholar
  89. 89.
    Braith R, Howard C, Fricker F, et al. Glucocoritcoid-induced osteopenia in adolescent heart transplant recipients. J Heart Lung Transplant 2000; 19(9): 840–5PubMedGoogle Scholar
  90. 90.
    Ip J, Fuster V, Badimon L, et al. Syndromes of acelerated arterosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990; 15(7): 1667–87PubMedGoogle Scholar
  91. 91.
    Leidig-Bruckner G, Hosch S, Dodidou P, et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transportation: a follow-up study. Lancet 2001; 357(9253): 342–7PubMedGoogle Scholar
  92. 92.
    Becker D, Chamberlain B, Swank R, et al. Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients. Am J Med 1988; 85(5): 632–8PubMedGoogle Scholar
  93. 93.
    Stamler J, Vaughan D, Rudd M, et al. Frequency of hypercholesterolemia after cardiac transplantation. Am J Cardiol 1988; 62(17): 1268–72PubMedGoogle Scholar
  94. 94.
    Holvoet P, Van Cleemput J, Collen D, et al. Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 2000; 20(3): 698–702PubMedGoogle Scholar
  95. 95.
    Holvoet P, Stassen J, Cleemput J, et al. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 1998; 18(1): 100–7PubMedGoogle Scholar
  96. 96.
    Hinkleman L, Nieman D. The effects of a walking program on body composition and serum lipids and lipoproteins in overweight women. J Sports Med Phys Fitness 1993; 33(1): 49–58PubMedGoogle Scholar
  97. 97.
    Lokey E, Tran Z. Effects of exercise training on serum lipid and lipoprotein concentrations in women: a meta-analyses. Int J Sports Med 1989; 10(6): 424–9PubMedGoogle Scholar
  98. 98.
    Nieman D, Warren B, O’Donnell K, et al. Physical activity and serum lipids and lipoproteins in elderly women. J Am Geriatr Assoc 1993; 41(12): 1339–44Google Scholar
  99. 99.
    Leon A, Sanchez O. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc 2001; 33 (6 Suppl.): S502–15PubMedGoogle Scholar
  100. 100.
    King A, Haskell W, Taylor C, et al. Group- vs home-based exercise training in healthy older men and women: a community-based clinical trial. JAMA 1991; 266(11): 1535–42PubMedGoogle Scholar
  101. 101.
    Cauley J, Kriska A, LaPorte R, et al. A two year randomized exercise trial in older women: effects on HDL-cholesterol. Atherosclerosis 1987; 66(3): 247–58PubMedGoogle Scholar
  102. 102.
    Seip R, Moulin P, Cocke T, et al. Exercise training decreases plasma cholesterol ester transfer protein. Arterioscler Thromb 1993; 13(9): 1359–67PubMedGoogle Scholar
  103. 103.
    Lindheim S, Notelovitz M, Feldman E, et al. The independent effects of exercise and estrogen on lipids and lipoproteins in postmenopausal women. Obstet Gynecol 1994; 83(2): 167–72PubMedGoogle Scholar
  104. 104.
    King A, Haskell W, Young D, et al. Long-term effects of varying intensities and formats of physical activity on participation rates, fitness, and lipoproteins in men and women aged 50 to 65 years. Circulation 1995; 91(10): 2596–604PubMedGoogle Scholar
  105. 105.
    Motoyama M, Sunami Y, Kinoshita F, et al. The effects of long-term low intensity aerobic training and detraining on serum lipid and lipoprotein concentrations in elderly men and women. Eur J Appl Physiol 1995; 70(2): 126–31Google Scholar
  106. 106.
    Ready A, Drinkwater D, Ducas J, et al. Walking program reduces elevated cholesterol in women postmenopause. Can J Cardiol 1995; 11(10): 905–12PubMedGoogle Scholar
  107. 107.
    Ready A, Maimark B, Ducas J, et al. Influence of walking volume on health benefits in women post-menopause. Med Sci Sports Exerc 1996; 28(9): 1097–105PubMedGoogle Scholar
  108. 108.
    Binder E, Birge S, Kohrt W. Effects of endurance exercise and hormone replacement therapy on serum lipids in older women. J Am Geriatr Soc 1996; 4(3): 231–6Google Scholar
  109. 109.
    Fox A, Thompson J, Butterfield G, et al. Effects of diet and exercise on common cardiovascular disease risk factors in moderately obese older women. Am J Clin Nutr 1996; 63(2): 225–33PubMedGoogle Scholar
  110. 110.
    Heikkinen J, Kyllonen E, Kurttila-Matero E, et al. HRT and exercise: effects on bone density, muscle strength and lipid metabolism: a placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women. Maturitas 1997; 26(2): 139–49PubMedGoogle Scholar
  111. 111.
    Schuit A, Schouten E, Miles T, et al. The effect of six months training on weight, body fatness and serum lipids in apparently healthy elderly dutch men and women. Int J Obes Relat Metab Disord 1998; 22(9): 847–53PubMedGoogle Scholar
  112. 112.
    Grandjean P, Crouse S, O’Brien B, et al. The effects of menopausal status and exercise training on serum lipids and the activities of intravascular enzymes related to lipid transport. Metabolism 1998; 47(4): 337–83Google Scholar
  113. 113.
    Klebanoff R, Miller V, Fernhall B. Effects of exercise and estrogen therapy on lipid profiles of postmenopausal women. Med Sci Sports Exerc 1998; 30(7): 1028–34PubMedGoogle Scholar
  114. 114.
    Stefanick M, Mackey S, Sheehan M, et al. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N Engl J Med 1998; 339(1): 12–20PubMedGoogle Scholar
  115. 115.
    Sunami Y, Motoyama M, Kinoshita F, et al. Effects of low-intensity aerobic training on the high-density lipoprotein cholesterol concentration in healthy elderly subjects. Metabolism 1999; 48(8): 984–8PubMedGoogle Scholar
  116. 116.
    Kraus W, Houmard J, Duscha B, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 2002; 347(19): 1483–92PubMedGoogle Scholar
  117. 117.
    American Heart Association. Heart and stroke statistical update. Dallas (TX): American Heart Association, 2002Google Scholar
  118. 118.
    Schrott H, Bittner V, Vittinghoff E, et al. Adherence to national cholesterol education program treatment goals in postmenopausal women with heart disease: The Heart and Estrogen/Progestin Replacement Study (HERS): the HERS Research Group. JAMA 1997; 277(16): 1281–6PubMedGoogle Scholar
  119. 119.
    Health United States. With socioeconomic status and health Chartbook. Hyattsville (MD): National Center for Health Statistics, 1998Google Scholar
  120. 120.
    Leung W, Lau C, Wong C. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemia patients. Lancet 1993; 341(8859): 1496–500PubMedGoogle Scholar
  121. 121.
    Williams S, Cusco J, Roddy M, et al. Impaired nitric-oxide mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996; 27(3): 567–74PubMedGoogle Scholar
  122. 122.
    Celermajer D, Sorensen K, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy adults. Circulation 1993; 88 (5 Pt 1): 2149–55PubMedGoogle Scholar
  123. 123.
    Taddei S, Virdis A, Mattei P, et al. Hypertension causes premature aging of endothelial function in humans. Hypertension 1997; 29(3): 736–43PubMedGoogle Scholar
  124. 124.
    Gokce N, Vita J, Bader D, et al. Effect of exercise on upper and lower extremity endothelial function in patients with coronary artery disease. Am J Cardiol 2002; 90(2): 124–7PubMedGoogle Scholar
  125. 125.
    Hambrecht R, Wolf A, Gielen S, et al. Effects of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 2000; 342(7): 454–60PubMedGoogle Scholar
  126. 126.
    Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996; 93(2): 210–4PubMedGoogle Scholar
  127. 127.
    Maiorana A, O’Driscoll G, Cheetham C, et al. The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes. J Am Coll Cardiol 2001; 38(3): 860–6PubMedGoogle Scholar
  128. 128.
    Stampfer M, Colditz G, Willett W, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses’ Health Study. N Engl J Med 1991; 325(11): 756–62PubMedGoogle Scholar
  129. 129.
    Hashimoto M, Akishita M, Eto M, et al. Modulation of endothelium-dependent flow-mediated dilation of the brachial artery by sex and menstrual cycle. Circulation 1995; 92(12): 3431–5PubMedGoogle Scholar
  130. 130.
    McKechnie R, Rubenfire M, Mosca L. Association between self-reported physical activity and vascular reactivity in postmenopausal women. Atherosclerosis 2001; 159(2): 483–90PubMedGoogle Scholar
  131. 131.
    Taddei S, Galetta F, Agostino V, et al. Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. Circulation 2000; 101(25): 2896–901PubMedGoogle Scholar
  132. 132.
    Gielen S, Erbs S, Linke A, et al. Home-based versus hospital-based exercise programs in patients with coronary artery disease: effects on coronary vasomotion. Am Heart J 2003; 145(1): J1–7Google Scholar
  133. 133.
    Maiorana A, O’Driscoll G, Dembo L, et al. Effect of aerobic and resistant exercise training on vascular function in heart failure. Am J Physiol Heart Circ Physiol 2000; 279(4): H1999–2005PubMedGoogle Scholar
  134. 134.
    Katz S, Yuen J, Bijou R, et al. Training improves endothelium-dependent vasodilation in resistance vessels of patients with heart failure. J Appl Physiol 1997; 82(5): 1488–92PubMedGoogle Scholar
  135. 135.
    Hambrecht R, Fiehn E, Weigl C, et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 1998; 98(24): 2709–15PubMedGoogle Scholar
  136. 136.
    Bergholm R, Makimattila S, Valkonen M, et al. Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivo. Atherosclerosis 1999; 145(2): 341–9PubMedGoogle Scholar
  137. 137.
    Higashi Y, Sasaki S, Sasaki N, et al. Daily aerobic exercise improves reactive hyperemia in patients with essential hypertension. Hypertension 1999; 33 (1 Pt 2): 591–7PubMedGoogle Scholar
  138. 138.
    Higashi Y, Sasaki S, Kurisu S, et al. Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide. Circulation 1999; 100(11): 1194–202PubMedGoogle Scholar
  139. 139.
    Clarkson P, Montgomery H, Mullen M, et al. Exercise training enhances endothelial function in young men. J Am Coll Cardiol 1999; 33(5): 1379–85PubMedGoogle Scholar
  140. 140.
    DeSouza CA, Shapiro LF, Clevenger CM, et al. Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation 2000; 102(12): 1351–7PubMedGoogle Scholar
  141. 141.
    Lavrencic A, Salobir BG, Keber I. Physical training improves flow-mediated dilation in patients with the polymetabolic syndrome. Arterioscler Thromb Vasc Biol 2000; 20(2): 551–5PubMedGoogle Scholar
  142. 142.
    Brendle DC, Joseph LJ, Corrett MC, et al. Effects of exercise rehabilitation on endothelial reactivity in older patients with peripheral arterial disease. Am J Cardiol 2001; 87(3): 324–9PubMedGoogle Scholar
  143. 143.
    Linke A, Schoene N, Gielen S, et al. Endothelial dysfunction in patients with chronic heart failure: systemic effects of lower-limb exercise training. J Am Coll Cardio 2001; 37(2): 392–7Google Scholar
  144. 144.
    Maiorana A, O’Driscoll G, Cheetham C, et al. The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes. J Am Coll Cardiol 2001; 38(3): 860–6PubMedGoogle Scholar
  145. 145.
    Fuchsjager-Mayrl G, Pleiner J, Wiesinger GF, et al. Exercise training improves vascular endothelial function in patients with type 1 diabetes. Diabetes Care 2002; 25(10): 1795–801PubMedGoogle Scholar
  146. 146.
    Schmidt A, Pleiner J, Bayerle-Eder M, et al. Regular physical exercise improves endothelial function in heart transplant recipients. Clin Transplant 2002; 16(2): 137–43PubMedGoogle Scholar
  147. 147.
    Green DJ, Walsh JH, Maiorana A, et al. Exercise-induced improvement in endothelial dysfunction is not mediated by changes in CV risk factors: pooled analysis of diverse patient populations. Am J Physiol Heart Circ Physiol 2003; 285(6): H2679–87PubMedGoogle Scholar
  148. 148.
    Goto C, Higash Y, Kimura M, et al. Effect of different intensities of exercise on endothelium-dependent vasodilation in humans: role of endothelium-dependent nitric oxide and oxidative stress. Circulation 2003; 108(5): 530–5PubMedGoogle Scholar
  149. 149.
    Walsh JH, Bilsborough W, Maiorana A, et al. Exercise training improves conduit vessel function in patients with coronary artery disease. J Appl Physiol 2003; 95(1): 20–5PubMedGoogle Scholar
  150. 150.
    Kobayashi N, Tsuruya Y, Iwasawa T, et al. Exercise training in patients with chronic heart failure improves endothelial function predominantly in the trained extremities. Circ J 2003; 67(6): 505–10PubMedGoogle Scholar
  151. 151.
    Edwards D, Schofield R, Lennon S, et al. Effect of exercise training on endothelial function in men with coronary artery disease. Am J Cardiol 2004; 93(5): 617–20PubMedGoogle Scholar
  152. 152.
    Vona M, Rossi A, Capodaglio P, et al. Impact of physical training and detraining on endothelium-dependent vasodilation in patients with recent acute myocardial infarction. Am Heart J 2004; 147(6): 1039–46PubMedGoogle Scholar
  153. 153.
    Maiorana A, O’Driscoll G, Dembo L, et al. Exercise training, vascular function, and functional capacity in middle-aged subjects. Med Sci Sport Exerc 2001; 33(12): 2022–8Google Scholar
  154. 154.
    Kubo S, Rector T, Bank A. Effects of cardiac transplantation on endothelium dependent dilation of the peripheral vasculature in congestive heart failure. Am J Cardiol 1993; 71(1): 88–93PubMedGoogle Scholar
  155. 155.
    Cavero P, Sudhir K, Galli F, et al. Effect of orthotopic cardiac transplantation on peripheral vascular function in congestive heart failure: influence of cyclosporine therapy. Am Heart J 1994; 127(6): 1581–7PubMedGoogle Scholar
  156. 156.
    Berkenboom G, Crasset V, Giot C, et al. Endothelial function of internal mammary artery in patients with coronary artery disease and in transplant recipients. Am Heart J 1998; 135(5): 488–94PubMedGoogle Scholar
  157. 157.
    Patel A, Kuvin J, DeNofrio D, et al. Peripheral vascular endothelial function correlates with exercise capacity in cardiac transplant recipients. Am J Cardiol 2003; 9(1): 897–9Google Scholar
  158. 158.
    Khan K, McKay H, Kannus P, et al. Physical activity and bone health. Champaign (IL): Human Kinetics, 2001Google Scholar
  159. 159.
    Bassey E, Ramsdale S. Increase in femoral bone density in young women following high-impact exercise. Osteoporos Int 1994; 4(2): 72–5PubMedGoogle Scholar
  160. 160.
    Heinonen A, Oja P, Kannus P, et al. Bone mineral density in female athletes representing sports with different loading characteristics of the skeleton. Bone 1995; 17(3): 197–203PubMedGoogle Scholar
  161. 161.
    Lohman T, Going S, Pamenter R, et al. Effects of resistance training on regional and total bone mineral density in premenopausal women: a randomized prospective study. J Bone Miner Res 1995; 10(7): 1015–24PubMedGoogle Scholar
  162. 162.
    Hatori M, Hasegawa A, Adachi H, et al. The effects of walking at the anaerobic threshold level on vertebral bone loss in postmenopausal women. Calcif Tissue Int 1993; 52(6): 411–4PubMedGoogle Scholar
  163. 163.
    Kohrt W, Ehsani A, Birge Jr S. Effects of exercise involving predominantly either joint-reaction or ground-reaction forces on bone mineral density in older women. J Bone Miner Res 1997; 12(8): 1253–61PubMedGoogle Scholar
  164. 164.
    Welsh L, Rutherford O. Hip bone mineral density is improved by high-impact aerobic exercise in postmenopausal women and men over 50 years. Eur J Appl Physiol Occup Physiol 1996; 74(6): 511–7PubMedGoogle Scholar
  165. 165.
    Smidt G, Lin S, O’Dwyer K, et al. The effect of high-intensity trunk exercise on bone mineral density of postmenopausal women. Spine 1992; 17(2): 280–5PubMedGoogle Scholar
  166. 166.
    Kerr D, Morton A, Dick I, et al. Exercise effects on bone mass in postmenopausal women are site-specific and load-dependent. J Bone Miner Res 1996; 11(2): 218–25PubMedGoogle Scholar
  167. 167.
    Berard A, Bravo G, Gauthier P. Meta-analysis of the effectiveness of physical activity for the prevention of bone loss in postmenopausal women. Osteoporos Int 1997; 7(4): 331–7PubMedGoogle Scholar
  168. 168.
    Kelley G. Exercise and regional bone mineral density in postmenopausal women. Am J Phys Med Rehabil 1998; 77(1): 76–87PubMedGoogle Scholar
  169. 169.
    Kelley G. Aerobic exercise and lumbar spine bone mineral density in postmenopausal women: a meta-analyses. J Am Geriatr Soc 1998; 46(2): 143–52PubMedGoogle Scholar
  170. 170.
    Wallace B, Cumming R. Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women. Calcif Tissue Int 2000; 67(1): 10–8PubMedGoogle Scholar
  171. 171.
    Wolff I, van Croonenborg J, Kemper H, et al. The effect of exercise training programs on bone mass: a meta-analyses of published controlled trials in pre- and postmenopausal women. Osteoporos Int 1999; 9(1): 1–12PubMedGoogle Scholar
  172. 172.
    Bonaiuti D, Shea B, Iovine R, et al. Exercise for preventing and treating osteoporosis in postmenopausal women (Cochrane Review). Available in The Cochrane Library; issue 3, 2004. Chichester: John Wiley & Sons, 2004: CD000333Google Scholar
  173. 173.
    Beck T, Ruff C, Mourtada F, et al. Dual-energy X-ray absorptiometry derived structural geometry for stress fracture prediction in male US Marine Corps recruits. J Bone Miner Res 1996; 11(5): 645–53PubMedGoogle Scholar
  174. 174.
    Beck T, Looker A, Ruff C, et al. Structural trends in the aging femoral neck and proximal shaft: analysis of the third national health and nutrition examination survey dual-energy X-rays absorptiometry data. J Bone Miner Res 2000; 15(12): 2297–304PubMedGoogle Scholar
  175. 175.
    Beck T, Oreskovic T, Stone KL, et al. Structural adaptation to changing skeletal load in progression toward hip fragility: the Study of Osteoporotic Fractures. J Bone Miner Res 2001; 16(6): 1108–19PubMedGoogle Scholar
  176. 176.
    Adami S, Gatil D, Braga V, et al. Site-specific effects of strength training on bone structure and geometry of ultradistal radius in postmenopausal women. J Bone Miner Res 1999; 14(1): 120–4PubMedGoogle Scholar

Copyright information

© Adis Data Information BV 2004

Authors and Affiliations

  • Crystal Whitney
    • 1
    • 2
  • Darren E. R. Warburton
    • 1
    • 2
  • Jiri Frohlich
    • 1
  • Sammy Y. Chan
    • 1
  • Heather McKay
    • 3
  • Karim Khan
    • 3
  1. 1.Healthy Heart ProgramSt Paul’s HospitalVancouverCanada
  2. 2.The Cardiovascular Physiology and Rehabilitation Laboratory, School of Human KineticsUniversity of British Columbia, Unit II Osborne CentreVancouverCanada
  3. 3.The Bone Health Research GroupUniversity of British ColumbiaVancouverCanada

Personalised recommendations